Table 4 Correlation between CD24 expression and clinicopathological factors in HBV-associated HCC.
Factors | N | CD24 | P | Spearman correlation coefficient | |
|---|---|---|---|---|---|
Low expression (n = 40) | High expression (n = 27) | ||||
TNM stage (%) | 0.048 | 0.265* | |||
I | 33 | 22 (55.0) | 11 (40.7) | ||
II | 22 | 15 (37.5) | 7 (25.9) | ||
III | 11 | 3 (7.5) | 8 (29.6) | ||
IV | 1 | 0 (0.0) | 1 (3.7) | ||
Histopathological grading (%) | 0.988 | ||||
Low | 13 | 8 (20.0) | 5 (18.5) | ||
Intermediate | 49 | 29 (72.5) | 20 (74.1) | ||
High | 5 | 3 (7.5) | 2 (7.4) | ||
Number of tumors (%) | 0.093 | ||||
1 | 57 | 36 (90.0) | 21 (77.8) | ||
2 | 7 | 4 (10.0) | 3 (11.1) | ||
>2 | 3 | 0 (0.0) | 3 (11.1) | ||
Maximum diameter of primary tumor (cm) (mean ± SD) | 67 | 6.49 ± 4.20 | 8.14 ± 5.22 | 0.156 | |
CK19 (mean ± SD) | 67 | 0.40 ± 1.55 | 0.59 ± 1.87 | 0.647 | |
CK18 (mean ± SD) | 67 | 4.33 ± 4.12 | 6.15 ± 3.95 | 0.075 | |
CD34 (mean ± SD) | 67 | 2.25 ± 3.31 | 3.81 ± 3.95 | 0.084 | |
Glypican-3 (mean ± SD) | 67 | 3.93 ± 3.87 | 4.00 ± 4.03 | 0.939 | |
Hepar-1 (mean ± SD) | 67 | 2.57 ± 3.40 | 1.41 ± 3.24 | 0.164 | |
Ki67(%) (mean ± SD) | 67 | 26.68 ± 20.61 | 28.44 ± 23.25 | 0.744 | |
